In the last 12 months, insiders at Context Therapeutics Inc. ($CNTX) filed 42 transactions with the SEC: 9 open-market purchases totaling $136,584 and 0 sales totaling $0. Net insider sentiment: net buying.
Context Therapeutics Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Lehr Martin A. (Chief Executive Officer) — 11 transactions totaling $99,578
- Minai-Azary Jennifer Lynn (Chief Financial Officer) — 5 transactions totaling $25,486
- Levit Alex C. (Chief Legal Officer, Corp. Sec) — 5 transactions totaling $11,520
- BERMAN RICHARD J (Director) — 2 transactions totaling $0
- West Linda (Director) — 3 transactions totaling $0
View all SEC Filings for Context Therapeutics Inc. (CNTX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Chagin Karen Deborah | Chief Medical Officer | A | Stock Option (right to buy) | 290000 | $0.00 | 290,000.0000 | 95,186,346 | 9999.99% | 0.30% |
| Feb. 19, 2026 | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 275000 | $0.00 | 275,000.0000 | 95,186,346 | 9999.99% | 0.29% |
| Feb. 19, 2026 | Lehr Martin A. | Chief Executive Officer | A | Stock Option (right to buy) | 815000 | $0.00 | 815,000.0000 | 95,186,346 | 9999.99% | 0.86% |
| Feb. 19, 2026 | Levit Alex C. | Chief Legal Officer, Corp. Sec | A | Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 95,186,346 | 9999.99% | 0.28% |
| June 12, 2025 | Pasternak Andy | Director | A | Stock Option (right to buy) | 138900 | $0.00 | 138,900.0000 | 58,416,141 | 9999.99% | 0.24% |
| June 12, 2025 | Walker Luke Nathaniel | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 12, 2025 | West Linda | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 12, 2025 | Kantoff Philip W. | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 12, 2025 | Smith Karen L. | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 12, 2025 | Stacey Jennifer Evans | Director | A | Stock Option (right to buy) | 123500 | $0.00 | 123,500.0000 | 58,416,141 | 9999.99% | 0.21% |
| June 6, 2025 | Minai-Azary Jennifer Lynn | Chief Financial Officer | P | Common Stock | 40010 | $0.64 | 80,010.0000 | 58,416,141 | 100.03% | 0.07% |
| June 6, 2025 | Levit Alex C. | Chief Legal Officer, Corp. Sec | P | Common Stock | 20000 | $0.58 | 81,983.0000 | 58,416,141 | 32.27% | 0.03% |
| June 9, 2025 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 100000 | $0.70 | 1,079,891.0000 | 58,416,141 | 10.21% | 0.17% |
| June 9, 2025 | Chagin Karen Deborah | Chief Medical Officer | A | Stock Option (right to buy) | 153000 | $0.00 | 153,000.0000 | 58,416,141 | 9999.99% | 0.26% |
| Feb. 13, 2025 | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 371800 | $0.00 | 371,800.0000 | 58,416,141 | 9999.99% | 0.64% |
| Feb. 13, 2025 | Levit Alex C. | Chief Legal Officer, Corp. Sec | A | Stock Option (right to buy) | 349900 | $0.00 | 349,900.0000 | 58,416,141 | 9999.99% | 0.60% |
| Feb. 13, 2025 | Dansky Ullmann Claudio | Chief Medical Officer | A | Stock Option (right to buy) | 174960 | $0.00 | 174,960.0000 | 58,416,141 | 9999.99% | 0.30% |
| Feb. 13, 2025 | Lehr Martin A. | Chief Executive Officer | A | Stock Option (right to buy) | 802700 | $0.00 | 802,700.0000 | 58,416,141 | 9999.99% | 1.37% |
| Jan. 13, 2025 | Pasternak Andy | Director | A | Stock Option (right to buy) | 20685 | $0.00 | 20,685.0000 | 58,416,141 | 9999.99% | 0.04% |
| Sept. 4, 2024 | Walker Luke Nathaniel | Director | A | Stock Option (right to buy) | 19315 | $0.00 | 19,315.0000 | 15,966,053 | 9999.99% | 0.12% |
| Sept. 4, 2024 | Smith Karen L. | Director | A | Stock Option (right to buy) | 19315 | $0.00 | 19,315.0000 | 15,966,053 | 9999.99% | 0.12% |
| Aug. 1, 2024 | Dansky Ullmann Claudio | Chief Medical Officer | A | Stock Option (right to buy) | 202170 | $0.00 | 202,170.0000 | 15,966,053 | 9999.99% | 1.27% |
| June 13, 2024 | BERMAN RICHARD J | Director | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 15,966,053 | 9999.99% | 0.31% |
| June 13, 2024 | Stacey Jennifer Evans | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 15,966,053 | 9999.99% | 0.16% |
| June 13, 2024 | Kantoff Philip W. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 15,966,053 | 9999.99% | 0.16% |
| June 13, 2024 | West Linda | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 15,966,053 | 9999.99% | 0.16% |
| March 21, 2024 | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 160115 | $0.00 | 160,115.0000 | 15,966,053 | 9999.99% | 1.00% |
| March 21, 2024 | Levit Alex C. | Chief Legal Officer, Corp. Sec | A | Stock Option (right to buy) | 153515 | $0.00 | 153,515.0000 | 15,966,053 | 9999.99% | 0.96% |
| March 21, 2024 | Lehr Martin A. | Chief Executive Officer | A | Stock Option (right to buy) | 291402 | $0.00 | 291,402.0000 | 15,966,053 | 9999.99% | 1.83% |
| May 31, 2023 | West Linda | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Stacey Jennifer Evans | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | BERMAN RICHARD J | Director | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| May 31, 2023 | Kantoff Philip W. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 21, 2023 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 5823 | $0.84 | 979,891.0000 | 0 | 0.60% | 0.00% |
| Feb. 13, 2023 | Minai-Azary Jennifer Lynn | Chief Financial Officer | A | Stock Option (right to buy) | 158001 | $0.00 | 158,001.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2023 | Levit Alex C. | Chief Legal Officer, Corp. Sec | A | Stock Option (right to buy) | 151505 | $0.00 | 151,505.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2023 | Lehr Martin A. | Chief Executive Officer | A | Stock Option (right to buy) | 287544 | $0.00 | 287,544.0000 | 0 | 9999.99% | 0.00% |
| Feb. 13, 2023 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 5606 | $0.87 | 974,068.0000 | 0 | 0.58% | 0.00% |
| Feb. 6, 2023 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 5040 | $0.97 | 968,462.0000 | 0 | 0.52% | 0.00% |
| Jan. 30, 2023 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 7027 | $0.70 | 963,422.0000 | 0 | 0.73% | 0.00% |
| Jan. 23, 2023 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 6839 | $0.72 | 956,395.0000 | 0 | 0.72% | 0.00% |
| Jan. 17, 2023 | Lehr Martin A. | Chief Executive Officer | P | Common Stock | 6783 | $0.74 | 949,556.0000 | 0 | 0.72% | 0.00% |